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Abstract.  One of the phenotypic hallmarks of migrat- 
ing endothelial cells, both in vivo and in vitro, is ex- 
pression of the urokinase-type plasminogen activator 
(u-PA), a key mediator of extracellular proteolysis. In 
the study reported here,  we have used an in vitro 
model of endothelial cell migration to explore the 
mechanism of this phenomenon.  We have found that 
wounding of an endothelial cell monolayer triggers a 
marked,  rapid and sustained increase in expression of 
a  specific high-affinity receptor for u-PA (u-PAr) on 
the surface of migrating cells.  Migrating cells dis- 
played an increase in the levels of u-PA and u-PAr 
mRNAs, and this increase was mediated by endoge- 
nous basic fibroblast growth factor (bFGF). We also 
show that the increase in u-PA activity on migrating 
ceils can be accounted for by an increase in receptor- 
bound u-PA, and that the increase in activity is also 
dependent on endogenous bFGF. These results demon- 
strate that the expression of plasmin-mediated proteo- 
lytic activity by migrating  endothelial cells is a conse- 
quence of increased production of both u-PA and its 
receptor,  and that this in turn is mediated by endoge- 
nous bFGE  This suggests that u-PA, produced at in- 
creased levels by migrating  cells, binds to u-PAr 
whose expression is upregulated on the same cells. 
These observations are in accord with the postulated 
role of u-PAr in mediating efficient and spatially re- 
stricted extracellular proteolysis, particularly in the 
context of cell migration. 
T  i-m vascular endothelium consists of a highly ordered 
monolayer of quiescent  non-migrating  cells,  which 
can be induced to migrate and replicate in a number 
of physiological  and pathological  settings.  This occurs for 
example during angiogenesis  in which new capillary blood 
vessels are formed from preexisting  vessels in response to 
angiogenic  stimuli.  During this process, microvascular  en- 
dothelial  cells locally degrade their basement membrane, 
and  subsequently  invade  the  surrounding  interstitial  ex- 
tracellular matrix within which they form a capillary sprout. 
The sprout develops into a functional  vessel after formation 
of a lumen (reviewed by DAmore and Thompson, 1987; Zet- 
ter,  1988). 
To breach the mechanical  barriers imposed by the base- 
ment membrane and surrounding  extracellular  matrix,  en- 
dothelial  cells use limited proteolytic degradation  of matrix 
components  at  regions  of contact  with  the  cell  surface 
(reviewed by Moscatelli and Rifldn, 1988; Pepper and Mon- 
tesano,  1991). Plasminogen activators  (PAs)  ~  are key medi- 
ators in this respect; they convert the widely distributed and 
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bovine microvascular endothelial; CPAE,  calf pulmonary artery  endo- 
thelial;  DCS,  donor calf serum;  PA,  plasminogen activators;  rhbFGF, 
recombinant human bFGF; tcu-PA, two-chain u-PA; u-PA, urokinase-type 
plasminogen activator. 
proteolytically inactive plasminogen to active plasmin, a pro- 
tease of tryptic specificity capable of directly degrading  cer- 
tain matrix components and also of activating other matrix- 
degrading  enzymes such as metalloproteases (reviewed by 
Saksela  and Rifldn,  1988). 
To mediate efficient and appropriate matrix remodelling 
during  angiogenesis,  extracellular  proteolysis must be con- 
fined to the  immediate  pericellular  environment.  This  is 
achieved in part by the spatial restriction of protease activity, 
which occurs through  the binding  of urokinase-type plas- 
minogen activator (u-PA) to a specific high affinity cell sur- 
face receptor (Vassalli et al.,  1985; Stoppelli et al.,  1985), 
and also as a consequence of protease inhibitor production, 
which prevents  excessive  matrix destruction (reviewed  by 
Pepper and Montesano,  1990).  The human u-PA receptor 
(u-PAr) is a 313 amino acid residue 55,000-65,000 Mr gly- 
coprotein linked  to the cell surface by a carboxy-terminal 
glycolipid anchor (Behrendt et al., 1990, 1991; Roldan et al., 
1990; Plough et al., 1991). u-PA binding to u-PAr occurs via 
an EGF-like domain in the amino-terminal  of u-PA (Appella 
et al.,  1987).  The u-PAr identified  on cultured endothelial 
cells is likewise a  55,000-Mr glycoprotein  which binds  the 
EGF-like domain of u-PA (Fibbi et al.,  1988; Miles et al., 
1988; Barnathan et al., 1990a,b; Mignatti et al., 1991; Had- 
dock et al.,  1991). Plasminogen/plasmin-binding  sites have 
also been identified on endothelial  cells (Bauer et al., 1984; 
Hajjar et al.,  1986; Miles et al.,  1988). 
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tributed to the leading edge of monocytes placed in a chemo- 
tactic gradient (Estreicher et al., 1990), and that u-PAr num- 
ber and affinity can be modulated by cytokines and phorbol 
esters (reviewed by Vassalli  et al.,  1991; Blasi,  1993), sug- 
gest that receptor expression and  function are highly dy- 
namic  in  nature.  However, the  important  question  as  to 
whether u-PAr expression is upregulated on migrating cells 
has not yet been addressed. Using an in vitro model in which 
endothelial cells can be induced to migrate by mechanically 
wounding a confluent monolayer, we have previously dem- 
onstrated that u-PA activity is  induced in cells migrating 
from the edges of such an experimental wound (Pepper et 
al.,  1987).  The studies described in this paper were per- 
formed in order to determine firstly, whether u-PAr expres- 
sion is upregulated on migrating endothelial cells, and sec- 
ondly,  whether the  increase in u-PA activity observed in 
these cells is due to a regional increase in u-PA synthesis, 
an increase in u-PA receptor expression, or a combination 
of both. 
Material and Methods 
Cell Culture 
Bovine microvascular endothelial (BME) cells from adrenal cortex (Furie 
et al., 1984) were grown in MEM, ¢x modification (Gibco AG, Basel, Swit- 
zerland), supplemented with 15 % heat-inactivated donor calf serum (DCS; 
Flow Laboratories, Baar,  Switzerland), penicillin (500 U/nil), and strep- 
tomycin (100/*g/ml). Cells were used between passages 15 and 20. 
Bovine aortic endothelial (BAE) cells isolated from scrapings of  adult bo- 
vine thoracic aortas according to the procedure of Gajdusek and Schwartz 
(1983)  and cloned by limiting dilution as previously described (Pepper et 
al., 1992a), were cultured in DMEM (GIBCO AG) supplemented  with 10 % 
DCS, penicillin (500 U/nil), and streptomycin (100/*g/nil). Cells were used 
between passages 8 and 11. 
Calf pulmonary artery endothelial (CPAE) cells, purchased from the 
American Type  Culture  Collection (Rockville,  MD),  were cultured  in 
DMEM supplemented with 20 % FCS serum (Flow Laboratories), penicil- 
lin  (500  U/ml),  and  streptomycin  (100  /,g/nil).  Cells  were  used  at 
passage 24. 
Endothelial cells were subcultured at a  1:4 or  1:5  split ratio in  1.5% 
gelatin-coated tissue culture dishes or flasks (Falcon Labware,  Becton- 
Dickinson Company, Lincoln Park,  NJ) or on poly-L-lysine (Sigma Im- 
munochemicals, St. Louis, MO)-coated glass microscope slides (for in situ 
hybridization studies). Culture media were changed every 2-3 d, and all ex- 
perimental manipulations, except those with varying cell density, were per- 
formed upon reaching confluence (5-7 d). The last medium change was al- 
ways 24 h before starting the experiment. 
Wound-edge Caseinolysis 
Seven parallel wounds were created with a 2.0-mm-wide rubber policeman 
in confluent BME monolayers in 35 mm tissue culture dishes (Falcon Lab- 
ware), the dish rotated through 90 ° and an additional set of parallel wounds 
created perpendicular to the first. Culture medium and detached cells were 
removed, the monolayers washed twice with PBS,  and  fresh complete 
medium added. 24 h later, monolayers were washed twice with PBS con- 
taining acid-treated BSA (1 mg/ml), and overlaid with a mixture containing 
2% non-fat dried milk, 0.8% agar, and plasminogen (40/*g/ml) in DMEM 
as previously described (Pepper et al.,  1987).  Dishes were incubated at 
37°C for 3 h and photographed under dark field illumination using a Zeiss 
ICM 405 inverted photomicroscope (Carl Zeiss, Oberkochen, Germany). 
To determine the effect of anti-bFGF antibodies on wound-edge caseinol- 
ysis, confluent monolayers of BME cells in 35  mm tissue culture dishes 
were mechanically wounded with a razor blade to mark the original wound 
edge (Biirk, 1973),  washed twice with serum-free a-MEM, and serum-free 
a-MEM containing 0.1% gelatin and either normal rabbit .y-globulins (200 
/*g/ml) or rabbit anti-recombinant human bFGF (rhbFGF) 7-globulins (200 
/*g/ml) (see below) added to the monolayers. Titration experiments revealed 
that 200 t~g/ml anti-rhbFGF "y-globulins were required for almost complete 
inhibition of cell-associated PA activity using the overlay technique (results 
not shown). 24 h after wounding, monolayers were overlaid as described 
above, and photographed after 3 h at 37°C under dark-field illumination and 
phase contrast microscopy, using a  Zeiss ICM 405 inverted photomicro- 
scope. 
"y-globulin fractions were prepared from normal rabbit serum or rabbit 
anti-rhbFGF antiserum (kindly provided by Drs. Y. Sato and D. B. Rifkin, 
New York University School of Medicine, New York) by two precipitations 
with 50% ammonium sulfate, dialyzed against distilled water or PBS and 
stored at -20°C. The preparation and characterization of the anti-rhbFGF 
antibodies has previously been described (Dennis and Rifldn, 1990). 
Zymography and Reverse Zymography 
Confluent monolayers of BME cells in 35  mm petri dishes were washed 
twice with serum-free ~x-MEM, and 1.5 ml serum-free ¢x-MEM containing 
200 KIU/ml Trasylol (Bayer-Pharma AG, Zurich, Switzerland) was added 
to each dish. Monolayers were multiple wounded as described above and 
the medium not changed after wounding. 15 h later cell extracts and culture 
supernatants were prepared as described (Vassalli  et al.,  1984;  Pepper et 
al., 1990);  Trasylol (200 KIU/ml) was added to cell extracts. Cell number 
was determined in a separate series of control and multiple-wounded dishes 
in parallel, and sample volume normalized accordingly. Zymography and 
reverse zymography were performed as previously described (Pepper et al., 
1990). 
To determine whether the increase in u-PA activity in multiple-wounded 
cultures was due to receptor-bound u-PA, multiple-wounded monolayers 
prepared in serum-free medium containing Trasylol (200 KIU/ml) as de- 
scribed above, were processed 18 h after wounding as follows: wounded 
monolayers were washed twice with PBS, and 1.0 ml, pH 3.0, buffer (0.1 M 
NaCI/50 mM glycine-HCl, pH 3.0), was added for 2 rain at room tempera- 
ture with gentle shaking. 500/*1, pH 7.4, buffer (0.15 M NaC1/0.5 M Hepes, 
pH  7.4)  was added to  neutralize the acid buffer, and  monolayers were 
washed  three  times  with  PBS  containing  1  mg/ml  acid-treated  BSA 
(PBS/BSA) on ice. 10 nM DFP-treated 55,000-Mr  human two-chain u-PA 
(tcu-PA) in binding medium (serum-free ~x-MEM containing 20 mM Hepes, 
pH 7.4,  1 mg/nfl acid-treated BSA, and 200 KIU/ml Trasylol) was added 
for 1 h at 4°C. Where relevant, a 400-fold molar excess of a peptide corre- 
sponding to the receptor-binding region of amino terminus of mouse u-PA 
(amino acids 13-33)  (Appella et al.,  1987) was added in binding medium 
15 re_in  before the addition of human I~u-PA. Monolayers were washed four 
times with PBS/BSA on ice and cell extracts prepared for zymography as 
described above. 
RNA Preparation  from Multiple-wounded  Cultures 
Approximately  50  parallel  wounds  were  created  with  a  1.0-mm-wide 
pointed rubber policeman in confluent monolayers in 100 mm tissue culture 
dishes (Falcon Labware), the dish rotated through 90 ° and an additional set 
of parallel wounds created perpendicular to the first. The medium was not 
changed after wounding. Total cellular RNA was extracted at the indicated 
times according to a modification of the method of Glisin et al. (1974) as 
previously described (Pepper et al.,  1990). 
To  determine the  effect of anti-bFGF antibodies on  wound-induced 
mRNA expression, two procedures were followed. In the first (designated 
"pre'), confluent monolayers were washed once with serum-free a-MEM 
and serum-free ¢x-MEM containing 0.1% gelatin and either normal rabbit 
~/-globulins  (200/*g/nil) or rabbit anti-rhbFGF -/-globulins (200/*g/ml) 
added to the monolayers. Monolayers were then multiple-wounded and the 
medium not changed thereafter. In the second (designated "post"), mono- 
layers were multiple-wounded, washed once with serum-free a-MEM, and 
serum-free a-MEM  containing  0.1%  gelatin  and  either  normal  rabbit 
3,-globulins  or rabbit anti-rhbFGF 3,-globulins (200/*g/ml) added. In both 
cases, total cellular RNA was extracted 4 h after wounding as described 
above. 
To determine the effect of  exogenous bFGF on u-PAR mRNA expression, 
rhbFGF (3 ng/mi) (provided by Dr. P Sarmientos, Farmitalia Carlo Erba, 
Milan, Italy) was added to confluent monolayers of BME cells in 100 mm 
tissue culture dishes, and total cellular RNA extracted at various time points 
thereafter as described above. 
Density and Replication Experiments 
Low-density cultures of BME cells were prepared by splitting confluent 
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1:6  in fresh medium. Fresh medium was added in parallel to confluent 
monolayers. Total cellular RNA was extracted 28 h later from low density 
and confluent cultures.  In some experiments, hydroxyurea (5 mM) was 
added to 1:3 split cultures after overnight spreading and attachment, and 
total cellular RNA extracted 24 h later. 
For inhibition of cell division in low density BME cultures, cells were 
seeded at 1  ×  105 cells per gelatin-coated 15 mm well of a 24-well plate 
(Costar,  Cambridge,  MA).  After overnight attachment and  spreading, 
medium  was  changed and  hydroxyurea (5  raM)  added.  15-18  h  later, 
[3H]thymidine (2 #Ci/mi) was added to each well. 4 h later, medium was 
removed, cells were washed with ice cold PBS, incubated on ice for 30 min 
in 10% TCA, washed with PBS, solubilized in 0.5 M NaOH for 30 min at 
room temperature, and 150-#1 aliquots counted in 3 ml Aqnassure scintilla- 
tion fluid (DuFont, Boston, MA). Percent inhibition of the mean of dupli- 
cate cultures was calculated as  100  -  (hydroxyurea  -  background  × 
100/control  -  background). 
For  inhibition of cell division in wounded monolayers, hydroxyurea 
(5 raM) was added to confluent monolayers in 100 mm tissue culture dishes 
(Falcon Labware), the monolayers were multiple wounded as described 
above, and the medium not changed thereafter. RNA was prepared as de- 
scribed above after a  further 4 h. 
Plasmid Construction and In Vitro Transcription 
pSP64-mUK.  A  625  bp  PstI-HindIH fragment (positions 42%1078)  of 
mouse u-PA cDNA clone pDB15  (Belin et al.,  1985) was subcloned into 
pSP64 (Melton et al.,  1984). 
pBSbUK. A 2.5-kb pair EcoRI-XhoI fragment of bovine u-PA cDNA 
(Kritzschmar et al., 1993) was subcloned into pBLUESCRIPT SK (Strata- 
gene Cloning Systems, Heidelberg, Germany). 
pBSbUPAr. A 1.2-kb pair EcoRI-XhoI fragment of  bovine u-PA receptor 
cDNA (Kfiitzschmar et al., 1993) was subcloned into pBLUESCRIPT SK. 
pSP65-hTA.  A  614-bp BglII-EcoRI fi'agment (positions 188-801) iso- 
lated from pW349F, a plasmid containing a 2.6-kb pair tissue-type PA (t-PA) 
cDNA insert (Fisher et al.,  1985),  was subcloned between the EcoRI and 
BamHI sites of pSP65 (Melton et al.,  1984). 
pSP64-mUK, pBSbUK, pBSbUPAr, and pSP65-hTA were linearized, 
respectively, with HincII, EcoRI, EcoRI, and HindIlI, and used as tem- 
plates for bacteriophage SP6 (pSP64-mUK, pSP65-hTA) and T7 (pBSbUK, 
pBSbUPAr) RNA polymerases (Melton et al.,  1984).  Transcription was 
performed exactly as described by Basso et al. (1986). 
Northern Blot Hybridization 
Total cellular RNA was denatured with glyoxal, electrophoresed in 1.2% 
agarose gels (5 #g RNA per lane), and transferred overnight onto nylon 
membranes (Hybond, Amersham, Arlington Heights, IL) as described by 
Thomas (1980).  Filters were baked under vacuum at 800C for 2 h, exposed 
to UV light (302 urn) for 30 s, and stained with methylene blue to reveal 
18S and 28S rRNA markers for determination of RNA integrity and even 
loading. Prehybridation, hybridization, and posthybridization washes were 
performed as previously described (Pepper et al.,  1990).  Filters were ex- 
posed to Kodak XAR-5 films (Eastman Kodak Co.,  Rochester, NY)  at 
-80°C between intensifying screens. Autoradiographs were scanned with 
a GenoScan laser scanner (Genofit, Geneva, Switzerland). 
In Situ Hybridization 
Confluent monolayers of BME or BAE cells on poly-L-lysine-coated  Color 
Frost glass microscope slides (Menzel-Gl~iser,  Germany) were mechani- 
cally wounded by scraping away half of the monolayer with a razor blade. 
The medium was not changed after wounding. Wounded monolayers were 
fixed 4 or 24 h after wounding in 4% paraformaldehyde in PBS for 15 rain 
at 40C, rinsed in PBS, and stored in 70% ethanol at 4°C until analyzed. 
1-3  x  106 cpm of 3H-labeled antisense RNA probe, prepared as described 
by Sappino et al. (1989),  was applied to each slide in 20-70 #1 of hybridiza- 
tion mixture. Prehybridization, hybridization and posthybridization washes 
were performed as  previously described (Sappino et  al.,  1989).  After 
graded ethanol dehydration, slides hybridized to 3H-labeled RNAs were 
immersed in NTB-2 emulsion (Eastman Kodak Co.) diluted 1:1 in deionized 
water. After 1--4-mo exposure, slides were developed in Kodak D-19 de- 
veloper, fixed in 30% Na thiosulfate, and counterstalned in methylene blue. 
Monolayers were photographed under dark-field illumination and transmit- 
ted light using an Axiophot photomieroscope (Carl Zeiss). 
Quantitation of in situ hybridization was performed on positive prints of 
dark-field images. Since it was rarely possible to mark the initial wound 
edge at the time of wounding, the migrating front of cells was used as the 
standard point of reference. The number of autorndiographic grains was 
counted in eight consecutive 100-#m-deep fields extending backwards from 
the migrating front into the remaining confluent monolayer, and the number 
of grains per cell in each field calculated as follows: (total number of grains 
-  background)/number of cells in that field. Background was calculated 
from regions of the slide devoid of cells. 
lzsl-labeled u-PA Binding to Wounded Endothelial 
Cell Monolayers 
Confluent monolayers of BME or BAE cells in gelatin-coated 35 mm petri 
dishes were wounded with a  rubber policeman, dead and detached cells 
were removed and 2 ml of fresh complete medium added. 4 or 24 h later 
wounded monolayers were washed twice with PBS, and  1.5 ml, pH 3.0 
buffer added for 2 rain at room temperature with gentle shaking. The acid 
buffer was neutralized by adding 750 td, pH 7.4 buffer, and monolayers were 
washed three  times  with  PBS/BSA  on  ice.  10  nM  125I-labeled  DFP- 
inactivated 55,000-Mr  human teu-PA in binding medium was added for 1 h 
at 4"C. Where relevant, a  10-400-fold molar excess of a peptide corre- 
sponding to the receptor-binding region of the amino terminus of mouse 
u-PA (see above) was added in binding medium 15 min before the addition 
of 125I-labeled u-PA. Monolayers were washed four times with PBS/BSA 
on ice and fixed with 3.5% paraformaidehyde in PBS for 30 min at room 
temperature. Fixed monolayers were washed three times with PBS, and 
overlaid with Ilford L4 emulsion. Autoradiographs were developed after 1 
or 2 wk. Quantitation was performed on positive prints of  dark-field images, 
and the migrating front of cells was used as the standard point of reference. 
The number of  autoradiographic grains was counted in six consecutive 100- 
#m-deep fields extending backwards from the migrating front into the re- 
maining confluent monolayer, and the number of  grains per cell in each field 
calculated as follows: (total number of grains  -  background)/number of 
cells in that field. Background was calculated from regions of the dish de- 
void of cells. 
For  iodination of u-PA,  55,000  Mr human tcu-PA (Serone,  Denens, 
Switzerland) was radiolabeled using iodogen (Pierce Chemical Co., Rock- 
ford, IL) and Na-125I (Amersbam International, Amersbam, UK) as de- 
scribed (Vassalli et al.,  1984),  and was used within 6 wk of iodination. 
125I-labeled u-PA had a specific activity of 2.6-3.4  ×  106 cpm/#g. 
Peptide synthesis.  A  21mer corresponding to amino acids  13-33  of 
mouse u-PA (Appella et al., 1987) was synthesized by the solid phase tech- 
nique using standard Boc/benzyl strategy on a model 430A machine (ABI 
Inc., Foster City, CA). Purified peptide eluted as a single peak on analytical 
HPLC and was further characterized by fast atom bombardment mass spec- 
trometry. The peptide was synthesized according to the correct sequence of 
mouse u-PA as described  by Belin et al. (1985),  in which amino acid number 
12 of the peptide was a lysine (K) and not a leucine (L) as published by Ap- 
pella et al.  (1987). 
Results 
The Increase in PA Activity on Migrating Cells Is 
Mainly Due to Receptor-bound u-PA 
Mechanical wounding of a confluent quiescent monolayer of 
endothelial cells induces cells lining the wound-edge to mi- 
grate and replicate (Sholley et al.,  1977).  We have  previ- 
ously demonstrated that u-PA activity is induced in migrat- 
ing BME cells (Pepper et al., 1987). In the present studies, 
multiple-wounding experiments were devised to maximize 
the yield of protein and mRNA from migrating and replicat- 
ing cells. When multiple-wounded monolayers of BME cells 
were overlaid 24 h after wounding, increased PA activity was 
observed over wound-edge cells (Fig.  1).  In these experi- 
ments  the  width  of the  resulting  wounds  (created  with a 
2-mm-wide rubber policeman) was chosen to avoid wound 
closure  and  maximize  cell  migration  at  the  time  the 
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monolayer.  A  confluent  monolayer  of BME cells  was  multiple 
wounded, washed, overlaid after 24 h with a thin layer of agar con- 
taining casein and plasminogen, and photographed under dark-field 
illumination after 3 h incubation at 37°C. (b) A higher magnifica- 
tion of the intersection of two perpendicular  wounds shown in a. 
The remaining monolayer (m), the wound devoid of cells (w), and 
plasminogen-dependent caseinolytic bands over cells at the wound 
edge (arrowheads)  are indicated in b. Bars: (a) 1 cm, (b) 500 #m. 
Figure  2.  Zymography and  reverse  zymography  of  multiple- 
wounded BME monolayers. (A) Zymography revealed an increase 
in u-PA in cell extracts (cells) and t-PA/PAI-1 complexes in culture 
supernatants (sup) of multiple-wounded monolayers (MW). C, con- 
trois. Reverse zymography revealed an increase in PAI-1 in both cell 
extracts and culture supernatants of  multiple-wounded cultures. (B) 
To determine whether the increase in cell-associated u-PA activity 
(lane/) was due to receptor-bound  u-PA, monolayers were acid 
treated to elute receptor-bound u-PA. Acid treatment removed most 
of the cell-associated u-PA activity (lane 2). Human tcu-PA bound 
efficiently to acid-treated monolayers (lane 3), and this could be in- 
hibited by preincubating the cells with a 400-fold molar excess of 
a peptide corresponding  to the receptor binding region of mouse 
u-PA (lane 4).  This  indicates  that  acid treatment  had unmasked 
u-PA receptors  previously occupied by endogenous bovine u-PA. 
Human and bovine u-PAs can easily be distinguished from one an- 
other due to differences in electrophoretic  mobility. 
monolayers were overlaid. No apparent difference was ob- 
served in the extent of caseinolysis over non-migrating cells 
when compared to cells in a non-wounded monolayer over- 
laid in parallel; this was true whether or not the medium was 
changed after wounding (results not shown). 
Zymographic analysis  of multiple-wounded  cultures  re- 
vealed an increase in cell-associated u-PA activity (Fig. 2 A), 
confirming our results previously obtained with the overlay 
technique (Pepper et al.,  1987).  Zymography also revealed 
an increase in t-PA, bound to PAId (Loskutoff et al., 1986), 
in the culture supernatant of multiple-wounded cultures (Fig. 
2 A). t-PA was distinguished from u-PA on the basis of inhibi- 
tion of u-PA catalytic activity by amiloride (Vassalli and Be- 
lin, 1987; Pepper et al., 1987). The t-PA/PAI-1  complex was 
characterized by Loskutoff et al.  (1986) on the basis of its 
recognition by antibodies to either t-PA or PAId. t-PA is usu- 
ally secreted into the culture medium (Moscatelli,  1986), 
which explains why it is not detected by the overlay tech- 
nique  (Pepper  et  al.,  1987),  which  primarily  assays  for 
cell-associated activity. Reverse zymography revealed an in- 
crease in PAId in multiple-wounded cultures (Fig. 2 A), ex- 
tending our previous observation that PAId  mRNA is in- 
creased in migrating endothelial cells (Pepper et al., 1992b). 
We have previously demonstrated that the PAI produced by 
BME cells which  is  detectable by reverse zymography is 
PAI-1  (Pepper et al.,  1991a). 
To determine whether the increase in cell-associated u-PA 
activity in multiple-wounded monolayers (Fig. 2 A) was due 
to receptor-bound u-PA, monolayers were acid treated. Acid 
treatment removed most of the cell-associated u-PA activity 
(Fig. 2 B, lane 2) which could be recovered in the acid wash 
(not shown). To verify that acid treatment had unmasked pre- 
viously  occupied  u-PA  binding  sites,  acid-treated  mono- 
layers were incubated with DFP-treated 55,000  M~ human 
tcu-PA. Partial inactivation by DFP treatment was necessary 
to  allow  for  simultaneous  detection  of human  55,000  Mr 
tcu-PA (added at a 10-fold higher concentration (10 nM) than 
the I4~ for human u-PA binding to bFGF-stimulated BME 
cells (0.8 riM) (Mignatti et al., 1991)) and bovine u-PA activi- 
ties, which can be distinguished from one another by differ- 
ences  in  electrophoretic  mobility  (bovine  u-PA  migrates 
faster).  Human  tcu-PA  bound  efficiently  to  acid-treated 
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wounded BME monolayers. Confluent monolayers of BME cells 
were multiple wounded, and the medium not changed thereafter. 
Total cellular RNA was extracted from non-wounded (Control) and 
multiple-wounded  monolayers  at the  times  indicated.  Northern 
blots  were  hybridized  with  32p-labeled u-PA,  u-PAr, and  t-PA 
cRNA probes.  Methylene blue staining revealed uniform loading 
of RNAs and intact 28S and 18S ribosomal markers after transfer 
and UV cross-linking  to nylon filters (bottom panel). 
monolayers (Fig. 2 B, lane 3), and this could be inhibited by 
preincubating the cells with a 400-fold molar excess of a pep- 
tide  corresponding  to  the  receptor binding  region  of the 
NH2 terminus of mouse u-PA (amino acids  13-33; Appella 
et al., 1987) (Fig. 2 B, lane 4). The murine peptide has previ- 
ously been shown to be an efficient competitor of human 
u-PA binding to BME cells (Mignatti et al.,  1991).  Bovine 
u-PA differs from murine and human sequences in the same 
region by two and three amino acids, respectively (Krfitzch- 
mar et al.,  1993). Human tcu-PA did not bind to BME cells 
in the absence of acid elution  (not shown),  demonstrating 
that most u-PA binding sites on these cells were occupied by 
endogenous bovine u-PA. 
u-PA and u-PA Receptor mRNAs Are Increased in 
Multiple-wounded Microvascular and Large Vessel 
Endothelial Cell Monolayers 
For mRNA analysis, the width of the initial wounds (created 
with a 1-mm-wide pointed rubber policeman) was chosen to 
allow for closure of the majority of wounds after 24 h  (see 
Fig. 1 in Pepper et al., 1992b). Northern blots of total cellu- 
lar RNA from multiple-wounded BME cell monolayers were 
hybridized with 32P-labeled murine or bovine u-PA, bovine 
u-PAr and human t-PA probes. (Where duplicate hybridiza- 
tions  were  performed  with  the  murine  and  bovine  u-PA 
probes,  identical  results  were  obtained).  This  revealed  a 
transient  increase  in  u-PA,  u-PAr  and  t-PA mRNA levels 
(Fig.  3).  The decrease in u-PAr mRNA was linked to the 
time of wound closure (Fig. 3). u-PA and t-PA mRNAs were 
maximally increased  16.9- and 6.1-fold,  respectively, after 
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Figure 4.  Quantitative  analy- 
sis  of u-PA, u-PA receptor, 
and  t-PA mRNA  induction 
in  multiple  wounded  mono- 
layers  of  BME,  BAE,  and 
CPAE cells.  Endothelial  cell 
monolayers  were  multiple- 
wounded, and the medium not 
changed thereafter.  Total cel- 
lular  RNA  was  extracted 
from  non-wounded  (A)  and 
multiple-wounded  (~)  mono- 
layers at the times  indicated. 
Northern  blots  were  hybrid- 
ized  with  riP-labeled  u-PA, 
u-PAr, and t-PA cRNA probes. 
Auto~p~  were  quanfi- 
tated  by  densitometric  scan- 
ning, and values are expressed 
relative to controls at 0 h. 
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after 4 h (Fig. 4). A similar increase in u-PA, u-PAr, and t-PA 
mRNAs was also observed in multiple-wounded monolayers 
of BAE and CPAE cells (Fig. 4). 
Cells migrating from the edges of a  wounded BME cell 
monolayer are moving to a state of low density (Pepper et 
al.,  1992b). In the present studies, we observed an increase 
in u-PA and u-PAr mRNAs in low-density BME cell cultures 
(results not shown). Addition of hydroxyurea (5 mM) to low- 
density cultures for 24 h, which inhibits [3H]thymidine in- 
corporation by 98 % (mean of  two separate experiments), did 
not reduce the increase in u-PA, u-PAr, or PAL1 mRNA lev- 
els (results not shown).  Similarly, addition of hydroxyurea 
(5 mM) to multiple-wounded BME cell monolayers for 4 h 
after wounding did not affect the wound-induced increase in 
u-PA, u-PAr, or t-PA mRNAs (results not shown). We have 
previously demonstrated that 4-h exposure to hydroxyurea  (5 
mM) inhibits pH]thymidine incorporation into low density 
BME cell cultures by 81%  (Pepper et al.,  1992b). 
The increase in u-PA and u-PA Receptor mRNAs Is 
Localized to Cells at the Wound Edge 
The localization of the increase in u-PA and u-PAr mRNAs 
was determined by in situ hybridization. Wounded mono- 
layers of BME  and  BAE  ceils  were hybridized with  3H- 
labeled anti-sense bovine u-PA and u-PAr RNA probes. In 
these experiments, BME or BAE cell monolayers on poly-L- 
lysine-coated  glass  microscope  slides  were  wounded  by 
scraping away half of the monolayer with a razor blade; this 
resulted in the absence of an opposing migrating front and 
hence of wound closure. An increased number of autoradio- 
graphic  grains  was  observed with  both  u-PA  and  u-PAr 
probes over cells at the edge of wounded BME and BAE cell 
monolayers (Figure 5 and results not shown). This increase 
was observed both at 4 hours (Fig. 5) and 24 h (results not 
shown) after wounding. The increase at 4 h was quantitated 
in  BME  cells  by  determining  the  number  of autoradio- 
graphic grains per cell in eight consecutive 100-/~m-deep 
Figure  5.  In  sire  hybridiza- 
tion  of wounded monolayers 
of  BME  cells.  Confluent 
monolayers  of  BME  cells 
on poly-L-lysine-coated glass 
microscope  slides  were 
wounded  by  scraping  away 
half of the  monolayer. Cul- 
tures were fixed after 4 h, sub- 
jeered to in situ hybridization 
using  3H-labeled  anti-sense 
bovine  u-PA (a  and  b)  and 
u-PAr (c and d) RNA probes. 
Cells  were  counterstained 
with methylene blue after in 
situ hybridization, a and c Are 
dark-field views of b  and d. 
Quantitation  was  performed 
in eight consecutive 100-/zm- 
wide  fields beginning at the 
leading edge (fie/d /)  as de- 
scribed  in  Materials  and 
Methods.  Results are  ex- 
pressed as the mean number 
of  autoradiographic  grains/ 
cell  from six  series of eight 
consecutive fields in cultures 
fixed 4 h after wounding, and 
are pooled from two experi- 
ments. Bar, 100/~m. 
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u-PA  to  wounded  BAE  monolayers. 
Wounded  monolayers  of  BAE  ceils 
were incubated with nSI-labeled DFP- 
treated  55,000 Mr human tcu-PA (10 
nM) 4 h (a)  and  24  h (b)  after  wound- 
ing,  and  subjected  to  autoradiography. 
In  c,  before  the  addition  of  mI-labeled 
u-PA,  wounded  monolayers  were 
preincubated with a z00-fold molar 
excess of a peptide corresponding to 
the  receptor  binding region  of  the 
NH2  terminus of mouse u-PA.  Bar, 
100 t~m. 
Pepper et al. u-PA Receptor  on Migrating  Endothelial  Cells  679 fields beginning at the leading front. This revealed a 3.0- and 
3.5-fold increase in u-PA and u-PAr mRNA levels, respec- 
tively, in cells in the field closest to the leading edge, when 
compared to cells in the field furthest from the migrating 
front (Fig. 5). No difference was observed in the number of 
autoradiographic grains per cell in non-migrating cells when 
compared to cells in a non-wounded monolayer hybridized 
in parallel in the same experiment (results not shown). The 
reasons for the apparent discrepancy between the levels of 
u-PA and u-PAr mRNA as quantitated by in situ hybridiza- 
tion (3.0- and 3.5-fold increase, respectively, after 4 h), com- 
pared to the levels seen in multiple-wounded cultures (14.8- 
and 20.8-fold increase, respectively, after 4 h), are not known. 
It is however possible that differences in the conditions (e.g., 
stringency) used for Northern blot and in situ hybridization 
may account for the apparent quantitative differences ob- 
served between these two techniques. 
u-PA Binding Sites Are More Abundant 
on Cells at the Wound Edge 
To  determine whether the increased expression of u-PAr 
mRNA in migrating ceils could be translated into an increase 
in the number of binding sites for u-PA, wounded mono- 
layers were incubated with mI-labeled DFP-treated 55,000- 
Mr human tcu-PA.  ~25I-labeled u-PA was used at a  10-fold 
higher  concentration  (10  nM)  than  the  /G  previously 
reported for human u-PA binding to bFGF-stimulated BME 
cells (0.8 nM) (Mignatti et al.,  1991). This revealed an in- 
crease in the number of u-PA binding sites as determined by 
autoradiography, on BME and BAE cells at the wound-edge, 
both 4 and 24 h after wounding (Fig. 6,a and b, and results 
not shown). The increase at 4 h was quantitated in BME and 
BAE cells by determining the number of autoradiographic 
grains per cell in six consecutive 100-gm-deep fields begin- 
ning at the leading front. This revealed a 3.9- and 5.1-fold in- 
crease in u-PAr binding sites in BME and BAE cells at the 
leading edge, respectively, when compared to cells in the 
field furthest from the  migrating  front  (Fig.  7).  Similar 
results were obtained using ~25I-labeled u-PA which had not 
been pretreated with DFP (results not shown). A large de- 
gree of heterogeneity was observed in the binding of t25I- 
Figure 7.  Quanfitation of the 
binding  of mI-labeled  u-PA 
to wounded BME and  BAE 
monolayers. Wounded mono- 
layers of BME or BAE cells 
were  incubated with  125I- 
labeled  DFP-treated human 
55,000 Mr tcu-PA (10 riM) 4 h 
after wounding,  and subjected 
to autoradiography.  Quantita- 
tion was performed in six con- 
secutive  100-~m-wide fields 
beginning at the leading edge 
(lqeM  1)  as  described  in 
Materials and Methods. Re- 
sults  are  expressed as  the 
mean  number  of autoradio- 
graphic grains/cell from nine 
series of six consecutive fields 
for both cell  types,  and axe 
pooled from two experiments. 
labeled  u-PA  to  individual  migrating  cells  (results  not 
shown). 
The specificity of the tzSI-labeled u-PA binding to wound- 
edge endothelial cells was verified by preincubating wounded 
monolayers with 10-400-fold molar excess of a peptide cor- 
responding to the receptor binding region of mouse u-PA 
(Appella et al., 1987). Preincubation with the mouse peptide 
at  a  10-fold  molar  excess  partially prevented  mI-labeled 
u-PA binding to wound-edge cells (results not shown); com- 
plete inhibition of binding was achieved by preincubation 
with a 40-fold or greater excess of peptide (Fig. 6 c). These 
results  demonstrate  that  u-PA  binding  to  migrating  en- 
dothelial cells is mediated by the u-PAr. 
It has previously been demonstrated that u-PA  binding 
sites are rapidly redistributed to the leading edge of mono- 
cytes placed in a  chemotactic gradient (Estreicher et all., 
1990).  In our present studies, u-PA did not appear to bind 
preferentially to the leading edge of migrating cells (Fig. 6, 
a and b), which may be due to the absence of a chemotactic 
gradient in wounded endothelial cell monolayers. 
The Wound-related Increase in u-PA Activity 
and u-PA and u-PA Receptor mRNA Expression Is 
Inhibited by Antibodies to bFGF 
Using the overlay technique which reveals an increase in 
u-PA activity associated with BME cells migrating from the 
wound-edge (Fig.  1),  we found that anti-bFGF antibodies 
completely abolished the increased u-PA activity normally 
seen over migrating cells (Fig. 8). To assess the mechanisms 
of this inhibition, u-PA and u-PAr mRNA levels were mea- 
sured  in  multiple-wounded monolayers  exposed  to  anti- 
rhbFGF antibodies. Two protocols were used: in the first, 
(designated ~pre'), antibodies were added to cultures before 
wounding, and not removed thereafter; in the second, (desig- 
nated "post"), monolayers were wounded, washed, and anti- 
bodies added thereafter. With both protocols, the wound- 
induced  increase  in  u-PA  and  u-PAr  mRNA  levels  was 
markedly reduced; u-PA mRNA was decreased by 62 and 
83%, while uPAr mRNA was described by 52 and 90% in 
"pre" and "post" experiments, respectively (Fig. 9). In addi- 
tion, the wound-induced increase in u-PA and u-PAr mRNAs 
was 84 and 60% greater when the medium was not changed 
after wounding (~re') than when it was (~ost"). Exogenous 
bFGF, which increases u-PA mRNA in confluent monolayers 
of BME cells (Pepper et al.,  1990),  also increased u-PAr 
mRNA levels in these cells, with a detectable increase in re- 
sponse to 300 pg/ml bFGF, and a maximal response at  1 
ng/ml bFGF with no further increase at higher concentra- 
tions (results not shown).  A  time course analysis with 3 
ng/ml revealed a  maximum 15.3-fold  increase after  12  h 
(Fig. 10). Taken together, these results demonstrate that the 
increase in u-PA activity and in u-PA and u-PAr mRNA lev- 
els  in  migrating BME  cells,  is  mediated by endogenous 
bFGF. 
Discussion 
Although it has consistently been observed that u-PA is ab- 
sent from resting endothelial cells in the intact organism 
(Rijken et al., 1980; Kristensen et al., 1984; Larsson et al., 
1984),  this enzyme is induced in endothelial cells during 
neovascularization of ovarian follicles, corpus luteum, and 
The Journal  of Cell Biology,  Volume 122, 1993  680 Figure 8. Effect of anti-bFGF antibodies on wound-edge BME cell u-PA activity. Confluent monolayers of BME ceils were wounded with 
a razor blade to mark the original wound edge (w), incubated in the presence of normal rabbit ~/-globulins (NRG; 200 #g/ml) (a and b) 
or anti-rbbFGF ~/-globulins  (200 #g/ml) (c and d) for 24 b, and overlaid with a thin layer of agar containing casein and plasminogen. 
Phase contrast (a) and corresponding darkfield views (b) of  the wound-edge region reveal an increase in u-PA-mediated  caseinolytic  activity 
as previously described (Pepper et al., 1987),  which extends to a few cell rows behind the original wound (w). Limits of caseinolysis are 
indicated by arrows in a  and by arrowheads in b. Anti-rhbFGF 3,-globulins markedly inhibit the increased caseinolysis over ceils at the 
wound edge (d), and reduce the distance of migration as well as the number of migrating cells which have crossed the original wound 
edge (c). Bar, 300 #m. 
maternal decidua (Bacharach et al., 1992),  and also during 
inflammation (GrCndahl-Hansen et al., 1989),  situations in 
which endothelial cell migration is induced. Consistent with 
these  observations,  we  have  previously demonstrated  that 
Figure 9. Effect of anti-bFGF antibodies on u-PA and u-PAr mRNA 
levels  in  multiple-wounded BME  monolayers.  Two  procedures 
were used. In the first, designated ,pre7 confluent monolayers were 
washed and serum-free c~-MEM containing 0.1% gelatin (C), and 
either normal rabbit ~,-globulins (N) (200 #g/ml) or rabbit anti- 
rhbFGF ~-globulins (a-F) (200 #g/ml) were added; monolayers 
were then multiple wounded and the medium not changed there- 
after. In the second, designated ~ost; monolayers were multiple- 
wounded, washed, and serum-free c~-MEM containing 0.1% gelatin 
and  either  normal  rabbit  ~/-globulins  or  rabbit  anti-rhbFGF 
~,-globulins were added. In both cases, total cellular RNA was ex- 
tracted  4  h  after  multiple wounding.  Confluent,  non-wounded 
monolayers were processed in the same way in parallel. Northern 
blots  were  hybridized with  32P-labeled  u-PA  and  u-PAr cRNA 
probes. Methylene blue staining revealed uniform loading of RNAs 
and intact 28S and 18S ribosomal markers after transfer and Lrv 
cross-linking to nylon filters (bottom panel). 
Pepper et al. u-PA Receptor on Migrating Endothelial Cells  681 Figure 10. Effect  of  endogenous  bFGF on u-PAr  mRNA expression 
in BME cells, rhbFGF (3 ng/ml) was added to confluent mono- 
layers of BME cells, and total cellular RNA extracted at the indi- 
cated time points thereafter. The northern blot was hybridized with 
a  32p-labeled u-PAr cRNA probe. Methylene blue  staining re- 
veaied uniform loading of RNAs and intact 28S and 18S ribosomal 
markers after transfer and UV cross-linking  to nylon filters (bottom 
panel). 
u-PA activity  is increased in migrating endothelial cells in re- 
sponse  to  mechanical  wounding in  vitro  (pepper  et  al., 
1987).  In this paper,  we demonstrate that this increase is 
mainly due to receptor-bound u-PA.  We also demonstrate 
that u-PA and u-PAr mRNA levels are increased in multiple- 
wounded endothelial cell monolayers, and by in situ hybrid- 
ization we show that this increase is localized to migrating 
cells,  u-PA  binding sites are also increased on migrating 
cells. Taken together, these results demonstrate that the in- 
duction of PA activity on migrating endothelial cells is due 
to  increased  production  of u-PA,  which  binds  to  u-PAr 
whose expression is upregulated on the same cells. 
What are the mechanisms responsible for the increase in 
u-PA and u-PAr expression in migrating endothelial cells? 
Wounding induces a number of alterations in cell functions 
in cells lining the wound edge, including cell division and 
cell migration. In this and a previous study (Pepper et al., 
1987), we have observed that inhibition of  BME cell division 
neither inhibits the induction of u-PA activity at the wound 
edge nor affects the increase in u-PA or u-PAr mRNA levels 
in multiple-wounded monolayers. Similarly, in low density 
cultures, in which endothelial cells both proliferate and mi- 
grate, the increase in u-PA, u-PAr,  and PAL1 mRNAs as 
compared to confluent cultures was not prevented by inhibi- 
tion of endothelial cell proliferation. Taken together, these 
results indicate that the observed changes in expression of 
different components of the PA system are likely to be as- 
sociated with cell migration rather than with proliferation. 
Sato and Rifkin (1988) have reported that wound-induced 
BME or BAE cell migration is decreased by addition of anti- 
bFGF antibodies to cultures after wounding, and Odekon et 
al. (1992) found that these antibodies decreased wound-edge 
PA activity in wounded BAE ceil monolayers. It has also 
been  demonstrated that u-PA activity is  increased in en- 
dothelial cells in response to bFGF (Moscatelli et al., 1986; 
Montesano et al., 1986),  and that bFGF increases the num- 
ber of u-PA binding sites on BME cells (Mignatti et al., 
1991).  It therefore seemed appropriate  to assess  whether 
anti-bFGF antibodies might affect  the increase in u-PA activ- 
ity and u-PA and u-PAr mRNA levels in migrating BME 
cells. Addition of the antibodies to cultures immediately af- 
ter wounding completely inhibited the increase in u-PA ac- 
tivity associated with these cells, confirming similar obser- 
vations by Odekon et al. (1992) with BAE cells. In addition, 
the increase in u-PA and u-PAr mRNAs in multiple-wounded 
monolayers was markedly inhibited both when the mono- 
layers were wounded in the presence of anti-bFGF antibod- 
ies, and also when these antibodies were added immediately 
after wounding. That bFGF is released into the medium as 
a consequence of wounding is suggested by the observation 
that the wound-induced increase in u-PA and u-PAr mRNAs 
was greater when the medium was not changed after wound- 
ing, and by the finding that the anti-bFGF antibodies were 
more efficient in reducing this increase when medium con- 
taining dead and damaged cells was removed after wound- 
ing. The results of this and other studies in which wound- 
edge phenomena can be inhibited by antibodies to bFGF 
(Sato and Rifkin, 1988; Odekon et al., 1992; Pepper et al., 
1992b; Pepper and Meda, 1992), suggest two possible mech- 
anisms of  bFGF release. Firstly, bFGF is released from dead 
or damaged cells as a consequence of wounding (McNeil et 
al.,  1989;  Gadjusek and Carbon,  1989;  Muthukrishnan et 
al.,  1991), and secondly, bFGF is released from migrating 
cells (McNeil et al.,  1989).  Although none of the observa- 
tions from this and previous studies allow us to exclude ei- 
ther  possibility,  our  results  clearly  suggest  that  bFGF 
released as a consequence of wounding is ~quired for the in- 
crease in u-PA, u-PAr, and PAL1 expression in migrating en- 
dothelial cells. 
u-PA has been implicated in processes of cell migration 
and tissue remodeling, while t-PA is believed to be involved 
mainly in intravascular thrombolysis (reviewed by Mosca- 
telli and Rifkin, 1988). Since our studies are concerned with 
endothelial cell migration,  we have focused on u-PA and 
u-PAr expression. However,  in this paper we have demon- 
strated  that  t-PA  is  also  increased  in  endothelial  cell 
monolayers in response to multiple wounding. The mecha- 
nisms for this increase are likely to differ from those dis- 
cussed above, since t-PA induction in BME cells in response 
to bFGF is minimal (Pepper et al.,  1990,  1991b). In addi- 
tion, t-PA mRNA is decreased in low-density BME cultures 
(M. S. Pepper, unpublished observation), in contrast to what 
we observed for u-PA and u-PAr mRNA. Further studies on 
the localization of the wound-induced increase in t-PA mRNA 
must await the availability of a homologous (bovine) cDNA 
for in situ analysis. 
What is the functional significance of the increase in u-PA 
receptor expression on migrating endothelial colls? The first 
and currently most apparent function is that of increasing the 
efficiency of extracellular proteolysis and local~ing it to the 
immediate pericellular envtronment (reviewed by Vassalli et 
al., 1991; Blasi, 1993). However, additional catalytically  in- 
dependent functions have also been attribOted  to the u-PA/ 
u-PAr interaction. These include mitogenesis (Rabbani et 
al.,  1990,  1992),  chemotaxis (Gudewicz and Gilboa, 1987; 
Del  Rosso  et  al.,  1990),  and differentiation (Nusrat  and 
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ing  chemotaxis  (Fibbi  et  al.,  1988)  and  chemokinesis 
(Odekon et al., 1992) have also been observed in endothelial 
cells.  Our findings on the co-induction of u-PA and u-PAr 
provide a  molecular basis  for the  u-PA/u-PAr  interaction 
responsible for both proteolytic and possible non-proteolytic 
functions of the u-PAr in migrating endothelial cells. They 
also point to the possible existence of an autocrine loop in 
which u-PA, through interactions with its receptor, increases 
its own synthesis  and possibly  modulates  the  synthesis  of 
other components  of the  PA-plasmin  system  in migrating 
cells. Indeed, Fibbi et al. (1990) have demonstrated that the 
catalytically inactive A chain is capable of stimulating u-PA 
release from human keratinocytes. 
Finally, in this paper we also demonstrate an increase in 
PAL1  activity  in  multiple-wounded  BME  cell  cultures, 
which extends our previous observation that PAId mRNA is 
increased  in  migrating  endothelial  cells  (Pepper  et  al., 
1992b).  However, the kinetics of the PAL1 mRNA increase 
were  different  from  those  observed  for  u-PA  and  u-PAr 
mRNA; the PAId increase was ephemeral, with an early de- 
crease independent of wound closure (Pepper et al., 1992b). 
We  suggest  that  expression of protease  inhibitors  at very 
early  stages  of cell migration might provide a mechanism 
which confines extracellular matrix degradation to the im- 
mediate periceUular environment. PAL1 bound to fibrin may 
protect blood clots from premature  dissolution (Reilly and 
Hutzelmann,  1992). This is particularly important in angio- 
genesis, which frequently occurs in situations of fibrin depo- 
sition such as wound healing. 
In summary,  we have  demonstrated that the increase in 
u-PA activity on migrating endothelial cells is mainly due to 
receptor-bound u-PA, which in turn can be accounted for by 
an increase in both u-PA and u-PAr expression by these cells. 
Furthermore,  the  increase in u-PA  activity  and u-PA  and 
u-PAr mRNA levels in migrating cells can be inhibited by an- 
tibodies to bFGE  The demonstration that the u-PAr is in- 
creased during cell migration strengthens  the hypothesis that 
cell-associated protease activity is an important element in 
the cohort of functions expressed by migrating and invading 
cells. 
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